236 related articles for article (PubMed ID: 25853800)
1. 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.
Uribe-Lewis S; Stark R; Carroll T; Dunning MJ; Bachman M; Ito Y; Stojic L; Halim S; Vowler SL; Lynch AG; Delatte B; de Bony EJ; Colin L; Defrance M; Krueger F; Silva AL; Ten Hoopen R; Ibrahim AE; Fuks F; Murrell A
Genome Biol; 2015 Apr; 16(1):69. PubMed ID: 25853800
[TBL] [Abstract][Full Text] [Related]
2. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
3. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
4. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation.
Ficz G; Branco MR; Seisenberger S; Santos F; Krueger F; Hore TA; Marques CJ; Andrews S; Reik W
Nature; 2011 May; 473(7347):398-402. PubMed ID: 21460836
[TBL] [Abstract][Full Text] [Related]
5. TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Calabrese R; Valentini E; Ciccarone F; Guastafierro T; Bacalini MG; Ricigliano VA; Zampieri M; Annibali V; Mechelli R; Franceschi C; Salvetti M; Caiafa P
Biochim Biophys Acta; 2014 Jul; 1842(7):1130-6. PubMed ID: 24735979
[TBL] [Abstract][Full Text] [Related]
6. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
Wang P; Yan Y; Yu W; Zhang H
Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.
Kroeze LI; van der Reijden BA; Jansen JH
Biochim Biophys Acta; 2015 Apr; 1855(2):144-54. PubMed ID: 25579174
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of ten-eleven translocation genes in endometrial cancers.
Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of ten-eleven translocation hydroxylase family proteins and 5-hydroxymethylcytosine in oligodendrocyte differentiation.
Zhao X; Dai J; Ma Y; Mi Y; Cui D; Ju G; Macklin WB; Jin W
Glia; 2014 Jun; 62(6):914-26. PubMed ID: 24615693
[TBL] [Abstract][Full Text] [Related]
10. Loss of 5-hydroxymethylcytosine and TET2 in oral squamous cell carcinoma.
Jäwert F; Hasséus B; Kjeller G; Magnusson B; Sand L; Larsson L
Anticancer Res; 2013 Oct; 33(10):4325-8. PubMed ID: 24122999
[TBL] [Abstract][Full Text] [Related]
11. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
Neri F; Dettori D; Incarnato D; Krepelova A; Rapelli S; Maldotti M; Parlato C; Paliogiannis P; Oliviero S
Oncogene; 2015 Aug; 34(32):4168-76. PubMed ID: 25362856
[TBL] [Abstract][Full Text] [Related]
12. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
[TBL] [Abstract][Full Text] [Related]
13. Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer.
Kinney SR; Pradhan S
Adv Exp Med Biol; 2013; 754():57-79. PubMed ID: 22956496
[TBL] [Abstract][Full Text] [Related]
14. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.
Yang H; Liu Y; Bai F; Zhang JY; Ma SH; Liu J; Xu ZD; Zhu HG; Ling ZQ; Ye D; Guan KL; Xiong Y
Oncogene; 2013 Jan; 32(5):663-9. PubMed ID: 22391558
[TBL] [Abstract][Full Text] [Related]
15. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation.
Hon GC; Song CX; Du T; Jin F; Selvaraj S; Lee AY; Yen CA; Ye Z; Mao SQ; Wang BA; Kuan S; Edsall LE; Zhao BS; Xu GL; He C; Ren B
Mol Cell; 2014 Oct; 56(2):286-297. PubMed ID: 25263596
[TBL] [Abstract][Full Text] [Related]
16. Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma.
Gambichler T; Sand M; Skrygan M
Melanoma Res; 2013 Jun; 23(3):218-20. PubMed ID: 23458759
[TBL] [Abstract][Full Text] [Related]
17. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells.
Blaschke K; Ebata KT; Karimi MM; Zepeda-Martínez JA; Goyal P; Mahapatra S; Tam A; Laird DJ; Hirst M; Rao A; Lorincz MC; Ramalho-Santos M
Nature; 2013 Aug; 500(7461):222-6. PubMed ID: 23812591
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxymethylcytosine-mediated alteration of transposon activity associated with the exposure to adverse in utero environments in human.
Sun M; Song MM; Wei B; Gao Q; Li L; Yao B; Chen L; Lin L; Dai Q; Zhou X; Tao J; Chen J; He C; Jin P; Xu Z
Hum Mol Genet; 2016 Jun; 25(11):2208-2219. PubMed ID: 27005421
[TBL] [Abstract][Full Text] [Related]
19. Tet family proteins and 5-hydroxymethylcytosine in development and disease.
Tan L; Shi YG
Development; 2012 Jun; 139(11):1895-902. PubMed ID: 22569552
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of CTCF binding by iAs directs TET-mediated reprogramming of 5-hydroxymethylation patterns in iAs-transformed cells.
Rea M; Gripshover T; Fondufe-Mittendorf Y
Toxicol Appl Pharmacol; 2018 Jan; 338():124-133. PubMed ID: 29175454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
